Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kuller LH, Shemanski L, Psaty BM, et al. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation 1995; 92:720–726.
Pignoli P, Tremoli E, Poli A, et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986, 74:1399–1406.
Poli A, Tremoli E, Colombo A, et al. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 1988; Apr, 70(3):253–261.
Smith SC Jr, Amsterdam E, Balady GJ, et al. Prevention Conference V: beyond secondary prevention: identifying the high risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II. Circulation 2000; 101:E12–E16.
Glagov S, Zarins CK, Masawa N, et al. Mechanical functional role of non-atherosclerotic intimal thickening. Front Med Biol Eng 1993; 5(1):37–43.
Guidelines committee. 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011–1053.
Grobbee DE, Bots ML. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med 1994; 236:567–573.
Meinders JM, Kornet L, Hoeks APG. Assessment of spatial inhomogeneities in intima media thickness along an arterial segment using its dynamic behavior. Am J Physiol Heart Circ Physiol 2003; 285:H384–H391.
Burke GL, Evans GW, Riley WA, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 1995; 26:386–391.
Newman AB, Naydeck B, Sutton-Tyrrell K, et al. Coronary artery calcification in older adults with minimal clinical or subclinical cardiovascular disease. J Am Geriatr Soc 2000; 48:256–263.
Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96:1432–1437.
Mannami T, Baba S, Ogata J: Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study. Arch Intern Med 2000; 160:2297–2303.
Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 1998; 101:2711–2719.
Taylor AJ, Kent SM, Flaherty PJ, et al. ARBITER: Arterial Biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 2002; 106:2055–2060.
Smilde TJ, van Wissen S, Wollersheim H, et al. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 2001; 357:577–581.
Furberg CD, Adams HP Jr, Applegate WB, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 1994; 90:1679–1687.
Hodis HN, Mack WJ, LaBree L, et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med 1996; 124:548–556.
Mercuri M, Bond MG, Sirtori CR, et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med 1996; 101:627–634.
Salonen R, Nyyssonen K, Porkkala E, et al. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995; 92:1758–1764.
Byington RP, Furberg CD, Crouse JR III, et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC–II). Am J Cardiol 1995; 76:54C–59C.
de Groot E, Jukema JW, van Boven AJ, et al. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study. Am J Cardiol 1995; 76:40C–46C.
Blankenhorn DH, Selzer RH, Crawford DW, et al. Beneficial effects of colestipol-niacin therapy on the common carotidartery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation 1993; 88:20–28.
Wiklund O, Hulthe J, Wikstrand J, et al. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study. Stroke 2002; 33:572–577.
Kastelein JJ, Sager PT, de Groot E, et al. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial. Am Heart J 2005; Feb, 149(2):234–239.
Wiklund O, Hulthe, J, Wikstrand, J, et al. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study. Stroke 2002; 33:572–577.
Hedblad B, Wikstrand J, Janzon L, et al. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intimamedia thickness: main results from the beta-blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation 2001; 103:1721–1726.
Borhani NO, Mercuri M, Borhani PA, et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis (MIDAS): a randomized controlled trial. JAMA 1996; 276:785–791.
Zanchetti A, Rosei E, Dal Palu C, et al. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. J Hypertens 1998; 16:1667–1676.
Simon A, Gariepy J, Moyse D, et al. Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes. Circulation 2001; 103:2949–2954.
Zanchetti A, Bond MG, Hennig M, et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on hAtherosclerosis (ELSA), a randomized, double blind, long-term trial. Circulation 2002; 106:2422–2427.
Tzou WS, Douglas PS, Srinivasan SR, et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol 2005; Aug 2, 46(3):457–463
Wallenfeldt K, Hulthe J, Fagerberg B. The metabolic syndrome in middle-aged men according to different definitions and related changes in carotid artery intima-media thickness (IMT) during 3 years of follow-up. J Intern Med 2005; 258:1–28.
Iglseder B, Cip P, Malaimare L, et al. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 2005; Jun, 36(6):1212–1217.
Vryonidou A, Papatheodorou A, Tavridou A, et al. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; May, 90(5):2740–2746.
Juonala M, Raitakari M, Viikari JSA, et al. Obesity in youth is not an independent predictor of carotid IMT in adulthood. The Cardiovascular Risk in Young Finns Study. Atherosclerosis 2006; Apr, 185(2):388–393.
Oren A, Vos LE, Uiterwaal CS, et al. Birth weight and carotid intima-media thickness: new perspectives from the atherosclerosis risk in young adults (ARYA) study. Ann Epidemiol 2004; Jan, 14(1):8–16.
Segers P, Rabben SI, De Backer J, et al. Functional analysis of the common carotid artery: relative distension differences over the vessel wall measured in vivo. J Hypertens 2004; 22:973–981.
Pitt B, Byington RP, Furberg CD, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Prevent investigators. Circulation 2000; 102:1503–1510.
Touboul PJ, Prati P, Scarabin PY, et al. Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging. J Hypertens Suppl 1992; 10:S37–S41.
Macioch JE, Patel SN, Bai CJ, et al. Contrast-enhanced ultrasound imaging measurement of carotid intimal medial thickness. J Am Coll Cardiol 2003; 41(suppl A):318A.
Secil M, Altay C, Gulcu A, et al. Automated measurement of intima-media thickness of carotid arteries in ultrasonography by computer software. Diagn Interv Radiol 2005; Jun, 11(2):105–108.
Wong M, Edelstein J, Wollman J, et al. Ultrasonic-pathological comparison of the human arterial wall: verification of intima-media thickness. Arterioscler Thromb 1993; 13:482–486.
de Groot E, Jukema JW, Montauban van Swijndregt AD, et al. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol 1998; Jun, 31(7):1561–1567.
Paul TK, Srinivasan SR, Wei C, et al. Cardiovascular risk profile of asymptomatic healthy young adults with increased femoral artery intima-media thickness: The Bogalusa Heart Study. Am J Med Sci 2005; Sep, 330(3):105–110.
Held C, Hjemdahl P, Eriksson SV, et al. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J 2001; Jan, 22(1):62–72.
Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561–1566.
Sundstrom J, Lind L, Arnlov J, et al. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 2001; 103:2346–2351.
Al-Mansour HA, Mulvagh SL, Pumper GM, et al. Usefulness of harmonic imaging for left ventricular opacification and endocardial border delineation by optison. Am J Cardiol 2000; Mar 15, 85(6):795–799, A10.
Verdecchia P, Angeli F, Pittavini L, et al. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients. Ital Heart J 2004; July, 5:505–510.
O’Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 2000; 36:326–340.
Calister TQ, Cooil B, Raya BP, et al. Coronary artery disease: improved reproducibility of calcium scoring with electron beam CT volumetic method. Radiology 1998; 208:807–814.
Schmermund A, Denktas AE, Rumberger JA, et al. Independent and incremental value of coronary artery calcium for predicting the extent of angiographic coronary artery disease: comparison with cardiac risk factors and radionuclide perfusion imaging. J Am Coll Cardiol 1999; 34:777–786.
Achenbach S, Moshage W, Ropers D, et al. Value of electron-beam computed tomography for the detection of high-grade coronary artery stenoses and occlusions. N Engl J Med 1998; 339:1964–1971.
Nakinishi T, Ito K, Imazu M, et al. Evaluation of coronary artery stenoses using electron-beam CT and multiplanar reformation. J Comput Assist Tomogr 1997; 21:121–127.
Budoff MJ, Georgiou D, Brody A, et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation 1996; 93:898–904.
Shavelle DM, Budoff MJ, Lamont DH, et al. Exercise testing and electron beam computed tomography in the evaluation of coronary artery disease. J Am Coll Cardiol 2000; July, 36(1):32–38.
Hoff JA, Chomka EV, Krainik AJ, et al. Age and gender distributions of coronary calcium scores detected by electron beam tomography in 35,246 adults. Am J Cardiol 2001; 87:1335–1339.
Wong ND, Kouwabunpat D, Vo AN, et al. Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: relation to age and risk factors. Am Heart J 1994; 127:422–430.
Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2005; Mar 15, 111(10):1313–1320.
Redberg RF, Vogel RA, Criqui MH, et al. 34th Bethesda Conference: Task Force #3-What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? J Am Coll Cardiol 2003; 41:1886–1898.
Brown BG, Morse J, Zhao XQ, et al. Electron-beam tomography coronary calcium scores are superior to Framingham risk variables for predicting the measured proximal stenosis burden. Am J Cardiol 2001; 88:23E–26E.
Devries S, Wolfkiel C, Shah V, et al. Reproducibility of the measurement of coronary calcium with ultrafast computed tomography. Am J Cardiol 1995; 75:973–975.
Mao S, Budoff MJ, Bakhsheshi H, et al. Improved reproducibility of coronary artery calcium scoring by electron beamtomography with a new electrocardiographic trigger method. Invest Radiol 2001; 36:363–367.
Shaw LJ, Raggi P, Schisterman E, et al. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003; 228:826–833.
Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. [see comment] [erratum appears in JAMA 2004 Feb 4;291(5):563]. [Journal Article] JAMA 2004; Jan 14, 291(2):210–215.
O’Malley PG, Feuerstein IM, Taylor AJ. Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial. JAMA 2003; 289:2215–2223.
Raggi P, Davidson M, Callister TQ, et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: beyond endorsed lipid lowering with EBT scanning (BELLES). Circulation 2005; Jul 26, 112(4):563–571 [Epub 11 Jul 2005].
Raggi P. Coronary calcium on electron beam tomography imaging as a surrogate marker of coronary artery disease. Am J Cardiol 2001; 87:27A–34A.
Auchenbach S, Hoffman U, Ferencik M, et al. Tomographic coronary angiography by EBCT and MDCT. Prog Cardiovasc Dis 2003; 46(2) (Septemeber/October):185–195.
Horiguchi J, Yamamoto H, Akiyama Y, et al. Variability of repeated coronary artery calcium measurements by 16-MDCT with retrospective reconstruction. AJR Am J Roentgenol 2005; Jun, 184(6):1917–1923.
Becker, C, Jakobs T, Aydemir S, et al. Helical and single slice conventional versus electron beam CT for quantification of coronary artery calcification. AJR Am J Roentgenol 2000; 174:543–547.
Neiman K, Cademartiri F, Lemos PA, et al. Reliable noninvasive coronary angiography with fast submillimeter multislice spiral computed tomography. Circulation 2002; 106:2051–2054.
Herzog C, Abolmaali N, Balzer JO, et al. Heart-rate-adapted image reconstruction of multidectector-row cardiac CT: influence of physiological and technical prequesite on image quality. Eur Radiol 2002; 12:1670–2678.
Kopp AF, Schroeder S, Knuetter A, et al. Non-invasive coronary angiography with high resolution multidetector-row computed tomography. Results in 102 patients. Eur Heart J 2002; 23:1714–1725.
Leber AW, Knez A, von Ziegler F, et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol 2005; 46:147–154.
Kopp AF, Schröder S, Baumbach A, et al. Non-invasive characterization of coronary lesion morphology and composition by multislice computed tomography: first results in comparison with intracoronary ultrasound. Eur Radiol 2000; 11:1607–1611.
Mochizuki T, Higashino H, Kayama Y, et al. Evaluation of wall motion using multi-detector-row CT: new application of post-processing interactive multi-planar animation of the heart. Radiology 2001; 221(P):413.
Lima JA, Desai MY. Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol 2004; September 15, 44(6):1164–1171.
Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001; Dec 27, 345(26):1863–1869.
Kim WY, Stuber M, Bonert P, et al. Three-dimensional black-blood cardiac magnetic resonance coronary vessels wall imaging detects positive arterial remodeling in patients with non-significant coronary artery disease. Circulation 2002; 106:296–299.
Yuan C, Zhang SX, Polissar NL, et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 2002; 105;181–185.
Viles-Gonzalez JF, Poon M, Sanz J, et al. In vivo 16-slice, multidetector-row computed tomography for the assessment of experimental atherosclerosis: comparison with magnetic resonance imaging and histopathology. Circulation 2004; Sep 14, 110(11):1467–1472 [Epub 7 Sep 2004].
Corti R, Fayad ZA, Fuster V, et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001; 104:249–252.
Chan SK, Jaffer FA, Botnar RM, et al. Scan reproducibility of magnetic resonance imaging assessment of aortic atherosclerosis burden. J Cardiovasc Magn Reson 2001; 3:331–338.
Kang X, Polissar NL, Han C, et al. Analysis of the measurement precision of arterial lumen and wall areas using high resolution MRI. Magn Reson Med 2000; 44:968–972.
Papamichael CM, Lekakis JP, Stamatelopoulos KS, et al. Ankle brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 2000; 86:615–618.
Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg 1969; 56:676–679.
Ouriel K, McDonnell AE, Metz CE, et al. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 1982; 91:686–693.
Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286:1317–1324.
Criqui MH, Fronek A, Klauber MR, et al. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 1985; 71:516–522.
Fowkes FG, Housley E, Macintyre CC, et al. Variability of ankle and brachial systolic pressures in the measurement of atherosclerotic peripheral arterial disease. J Epidemiol Community Health 1988; 42:128–133.
Neunteufl T, Heher S, Katzenschlager R, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000; 86:207–210.
Patti G, Pasceri V, Melfi R, et al. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation 2005; Jan 4, 111(1):8–10.
Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974; 34:48–55.
Chilian WM, Marcus ML. Phasic coronary blood flow velocity in intramural and epicardial coronary arteries. Circ Res 1982; 50:775–781.
Feinstein SB, Voci P, Pizzuto F. Noninvasive surrogate markers of atherosclerosis. Am J Cardiol 2002; 89:31C–43C; discussion 43C–44C.
Hozumi T, Yoshida K, Ogata Y, et al. Noninvasive assessment of significant left anterior descending coronary artery stenosis coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 1998; 97:1557–1562.
Hozumi T, Yoshida K, Akasaka T, et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler hechocardiography: comparison with invasive technique. J Am Coll Cardiol 1998; 32:1251–1259.
Caiati C, Montaldo C, Zedda N, et al. New noninvasive method for coronary flow reserve assessment: contrast–enhanced transthoracic second harmonic echo Doppler. Circulation 1999; 99:771–778.
Caiati C, Zedda N, Montaldo C, et al. Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine: anoninvasive, rapid and effective method for coronary flowreserve assessment. J Am Coll Cardiol 1999; 34:122–130.
Pizzuto F, Voci P, Sinatra R, et al. Noninvasive assessment of coronary flow velocity reserve before and after angioplasty in a patient with mammary graft stenosis. Ital Heart J 2000; 1:636–639.
Pizzuto F, Voci P, Mariano E, et al. Assessment of flow velocity reserve by transthoracic Doppler echocardiography andvenous adenosine infusion before and after left anteriordescending coronary artery stenting. J Am Coll Cardiol 2001; 38:155–162.
Pizzuto F, Voci P, Mariano E, et al. Noninvasive coronary flow reserve assessed by transthoracic coronary Doppler ultrasound in patients with left anterior descending coronary artery stents. Am J Cardiol 2003; 91:522–526.
Piek JJ, Boersma E, Voskuil M, et al. The immediate and long term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial Europe. Eur Heart J 2001; 22:1725–1732.
Serruys PW, di Mario C, Piek J, et al. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe). Circulation 1997; 96:3369–3377.
Kruger S, Koch KC, Kaumanns I, et al. Clinical significance of fractional flow reserve for evaluation of functional lesion severity in stent restenosis and native coronary arteries. Chest 2005; Sep, 128(3):1645–1649.
Kumamoto M, Nakashima Y, Sueishi K. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol 1995; 26:450–456.
Wilson SH, Heurmana J, Leuman L, et al. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation 2002; 105:415–418.
Moreno PR, Purushothaman KR, Fuster V, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 2004; Oct 5, 110(14):2032–2038.
Martin RP, Lerakis S. Contrast for vascular imaging. Cardiol Clin 22(2):13–320.
Barger AC, Beeukes R, Lainey LL, et al. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984; 310:175–177.
Folkman T. Angiogenesis. In Biology of Endothelial Cells. Jaffe EA (ed.). Boston: Martinus Nijhoff Publishers; 1984:412–428.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this chapter
Cite this chapter
Chugh, A.R. et al. (2007). The Clinical Use of Noninvasive Modalities in the Assessment of Atherosclerosis. In: Davidson, M.H., Toth, P.P., Maki, K.C., Gotto, A.M. (eds) Therapeutic Lipidology. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-533-6_18
Download citation
DOI: https://doi.org/10.1007/978-1-59745-533-6_18
Publisher Name: Humana Press
Print ISBN: 978-1-58829-551-4
Online ISBN: 978-1-59745-533-6
eBook Packages: MedicineMedicine (R0)